How to Respond to FDA Form 483s and Warning Letters
Many medical device manufacturers receive FDA warning letters due to lack of preparation for the FDA inspection and/or an inadequate response to an FDA Form 483. The manner in which manufacturers respond to the 483 is critical in mitigating potential compliance risks and preventing the issuance of a warning letter. This article by NSF’s Kristen Grumet, published in Medical Design and Outsourcing, explains six key steps manufacturers can take when issued the FDA Form 483.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
NSF Acquires PSILab, Inc., an Advanced Plastic Pipe and Materials Testing Laboratory
March 18, 2024The acquisition extends NSF’s service offerings in the water industry, furthering its commitment to the quality, performance and safety of water products globally.
Read the Story
Dwayne “The Rock” Johnson’s ZOA+ Powder Earns NSF Certified for Sport® Certification
March 4, 2024New Pre-Workout Powder Joins Elite Group of NSF Certified For Sport® Dietary Supplements.
Read the Story
February 2024 Pharma News Update
February 15, 2024The February 2024 update looks at the FDA’s guidance on conducting remote regulatory assessments and more.
Read the Story
Nearly 70% of Americans Say Animal Wellness Plays an Important Role in Purchasing Decisions
February 14, 2024New research from NSF demonstrates a shift towards ethical consumerism with a rising demand for consistency and compliance among meat producers.
Read the Story